Several components of the IL-23 signaling pathway are also confirmed as IBD susceptibility genes, including IL23R, IL12B, STAT3, and JAK2, which help to explain the regulatory effect of these mediators on intestinal mucosal immune homeostasis in IBD patients [160, 167, 171–173]. This evidence concerns the gene STAT3 and inflammatory bowel disease.